IP Library Granted Patent US 7,683,168
Granted Patent B2
US 7,683,168 · App. 11/404,632 · Granted Mar 23, 2010

Compositions of novel opioid compounds and method of use thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,683,168
App. No.
11/404,632
Granted
Mar 23, 2010
Kind
B2
Abstract

Diarylmethylpiperazine compounds are described, which are useful as mu and/or delta receptor opioid compounds, without central side effects. Pharmaceutical compositions containing such compounds are variously useful for peripheral or non-centrally mediated indications, including peripherally mediated and neuropathic pain, urogenital tract disorders, overactive bladder, urinary incontinence, sexual disorders, premature ejaculation, cough, lung edema, cardiac disorders, cardioprotection, gastro-intestinal disorders, diarrhea, irritable bowl syndrome, functional distention, immuno-modulation and anti-tumor activity.

Claims (7)

1. A compound of the formula

wherein:

Z is H, O(CH 2 )nCH 3 , wherein n=0 to 4, or OH;

X is —C═O which is on the meta or para position of the phenyl ring;

DL is a group having a nitrogen that is covalently bonded to the carbon atom of group X;

R 1 is C 1 -C 6 alkyl, C 1 -C 6 alkenyl, C 1 -C 6 cycloalkylmethyl, arylalkyl having C 5 -C 10 aryl and C 1 -C 6 alkyl moieties, halobenzyl or carboxybenzyl; and

wherein the DL is selected from the group consisting of:

Assignments (10)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 9, 2023
From: DMK PHARMACEUTICALS CORPORATION
To: DMK PHARMACEUTICALS CORPORATION
Reel/Frame 063903/0246 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2023
From: VERSI GROUP LLC
To: DMK PHARMACEUTICALS CORPORATION
Reel/Frame 063773/0672 →
ASSIGNMENT OF LIENS Recorded May 21, 2013
From: ENTHALPY ANALYTICAL, INC. AND ENTA HOLDING LLC
To: VERSI GROUP, LLC
Reel/Frame 030453/0956 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2012
From: VERSI, EBRAHIM
To: VERSI GROUP, LLC
Reel/Frame 028186/0765 →
CHANGE OF NAME Recorded Mar 26, 2012
From: MOUNT COOK BIOSCIENCES, INC.
To: MT. COOK PHARMA, INC.
Reel/Frame 027930/0493 →
SALE OF ASSETS Recorded Jun 28, 2011
From: MT COOK PHARMA, INC.
To: VERSI, EBRAHIM
Reel/Frame 026511/0230 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2010
From: ENTHALPY ANALYTICAL, INC.
To: ENTA HOLDING LLC
Reel/Frame 024278/0419 →
EQUITABLE LIEN Recorded Feb 17, 2010
From: MT. COOK PHARMA, INC. (PREVIOUSLY DOING BUSINESS AS MOUNT COOK BIOSCIENCES, INC.)
To: VERSI, EBRAHIM
Reel/Frame 023957/0442 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2009
From: MT. COOK PHARMA, INC.
To: ENTHALPY ANALYTICAL, INC.
Reel/Frame 023486/0174 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2006
From: ARDENT PHARMACEUTICAL, INC.
To: MOUNT COOK BIOSCIENCES, INC.
Reel/Frame 018207/0396 →